Mineralys Therapeutics Inc
MLYSLatest QuantConomy context for MLYS: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
Mineralys Therapeutics Inc
QuantConomy has a structured record for MLYS. More descriptive asset metadata will appear here when the platform record includes it.
- Symbol
- MLYS
- Name
- Mineralys Therapeutics Inc
- Coverage
- 3 market/data records
- Sources
- fmp alphavantage alpaca sec nasdaq
Recent signals for MLYS
Scored rows are pulled from the same signal API used by the digests.
| Signal | Direction | Score | Observed | Reason |
|---|---|---|---|---|
| insider trade large sale | slightly bearish | 38 | Jun 30, 10:48 PM | Congleton Jon sold MLYS shares ($1.50M) - 58,000 shares - [weak slightly bearish signal] |
| insider trade large sale | slightly bullish | 30 | Jun 30, 10:47 PM | Warren Eric exercised options for MLYS shares ($1.38M) - 104,124 shares - [very weak slightly bullish signal] |
| earnings earnings release | neutral | 40 | Mar 12, 12:00 AM | MLYS filed an earnings release (8-K Item 2.02 - Results of Operations and Financial Condition) on 2026-03-12. Release-event signal only: confirms results were published, not the figures vs. estimates (no surprise/guidance read). |
EARNINGS signals are experimental: currently limited to neutral pre-earnings calendar awareness (no transcript analysis).
PRICE signals are experimental: realized 30-day directional accuracy is ~18% (short-horizon price moves tend to mean-revert). They are automatically down-weighted in composite scores but served raw here. Do not use them as standalone trade advice.
Market coverage
| Market | Exchange | Source | Asset record |
|---|---|---|---|
| MLYS | NASDAQ | fmp | Mineralys Therapeutics, Inc. |
| MLYS | NASDAQ | alphavantage | Mineralys Therapeutics Inc |
| MLYS | NASDAQ | alpaca | Mineralys Therapeutics, Inc. Common Stock |
Recent insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | Congleton Jon | Chief Executive Officer | sale | 58,000 | $25.94 | $1,504,706 | 4 on EDGAR |
| Jun 26, 2026 | Warren Eric | Chief Commercial Officer | exercise | 104,124 | $13.24 | $1,378,602 | 4 on EDGAR |
| Jun 17, 2026 | Karydas Daphne | Insider | exercise | 3,000 | $12.02 | $36,060 | 4 on EDGAR |
| Jun 15, 2026 | Rodman David Malcom | Chief Medical Officer | exercise | 3,542 | $10.20 | $36,128 | 4 on EDGAR |
| Jun 10, 2026 | Rodman David Malcom | Chief Medical Officer | exercise | 2,170 | $16.00 | $34,720 | 4 on EDGAR |
| May 18, 2026 | Rodman David Malcom | Chief Medical Officer | exercise | 417 | $15.44 | $6,438 | 4 on EDGAR |
| May 11, 2026 | Rodman David Malcom | Chief Medical Officer | exercise | 2,171 | $16.00 | $34,736 | 4 on EDGAR |
| Apr 17, 2026 | Rodman David Malcom | Chief Medical Officer | exercise | 416 | $15.44 | $6,423 | 4 on EDGAR |
| Apr 13, 2026 | Congleton Jon | Chief Executive Officer | sale | 15,730 | $26.83 | $421,979 | 4 on EDGAR |
| Apr 13, 2026 | Rodman David Malcom | Chief Medical Officer | exercise | 6,349 | $1.08 | $6,857 | 4 on EDGAR |
| Apr 9, 2026 | Rodman David Malcom | Chief Medical Officer | exercise | 2,170 | $16.00 | $34,720 | 4 on EDGAR |
| Mar 31, 2026 | Congleton Jon | Chief Executive Officer | sale | 19,364 | $25.50 | $493,794 | 4 on EDGAR |
| Mar 31, 2026 | Karydas Daphne | Insider | exercise | 3,000 | $12.02 | $36,060 | 4 on EDGAR |
| Mar 27, 2026 | RA CAPITAL MANAGEMENT, L.P. | Director | purchase | 310,700 | $23.67 | $7,354,269 | 4 on EDGAR |
| Mar 17, 2026 | Rodman David Malcom | Chief Medical Officer | exercise | 417 | $15.44 | $6,438 | 4 on EDGAR |
| Mar 12, 2026 | Rodman David Malcom | Chief Medical Officer | exercise | 6,348 | $1.08 | $6,856 | 4 on EDGAR |
| Mar 9, 2026 | Rodman David Malcom | Chief Medical Officer | exercise | 2,171 | $16.00 | $34,736 | 4 on EDGAR |
| — | Warren Eric | Chief Commercial Officer | — | — | — | — | 3 on EDGAR |
| Feb 19, 2026 | Levy Adam Scott | CFO and Secretary | grant | 39,900 | $0.00 | $0 | 4 on EDGAR |
| Feb 19, 2026 | Congleton Jon | Chief Executive Officer | grant | 140,900 | $0.00 | $0 | 4 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Query MLYS context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access